Anti-inflammatory effect of semaglutide: updated systematic review and meta-analysis

Simple item page
dc.contributor.authorWalter Masson
dc.contributor.authorMartín Lobo
dc.contributor.authorJuan Patricio Nogueira
dc.contributor.authorAlfredo Matias Rodriguez-Granillo
dc.contributor.authorLeandro Ezequiel Barbagelata
dc.contributor.authorDaniel Siniawski
dc.date.accessioned2026-08-25T23:23:52Z
dc.date.available2026-08-25T23:23:52Z
dc.date.issued2024-07-05
dc.description.abstractThe anti-inflammatory effect of semaglutide may represent one of the mechanisms underlying its cardiovascular benefits in patients with type 2 diabetes mellitus and/or obesity. This systematic review and meta-analysis, conducted according to PRISMA guidelines, evaluated randomized clinical trials assessing the effect of semaglutide on C-reactive protein (CRP) levels compared with placebo or other glucose-lowering therapies. Thirteen randomized clinical trials involving 26,131 participants were included. Semaglutide was associated with significantly lower CRP levels compared with both placebo and control groups, regardless of treatment regimen or population evaluated. These findings support a significant anti-inflammatory effect of semaglutide that may contribute to its cardiovascular benefits.
dc.description.sponsorshipSemaglutide; Inflammation; C-reactive protein; GLP-1 receptor agonists; Meta-analysis.
dc.identifier.urihttp://repositorio.uia.ac.cr/handle/123456789/5133
dc.language.isoen
dc.titleAnti-inflammatory effect of semaglutide: updated systematic review and meta-analysis
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
fcvm-11-1379189.pdf
Size:
11.89 MB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed to upon submission
Description:
Download
Collections
Medicina